Recombinant Human ADAMTS1 is prone to proteolytic cleavage at C-terminus. The predominant form of the purified protein lacks the His tag.
Protein/Peptide Type
Recombinant Enzymes
Gene
ADAMTS1
Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Theoretical MW
54 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
66 kDa, reducing conditions
Publications
Read Publications using 2197-AD in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
6 months from date of receipt, -20 to -70 °C as supplied.
3 months, -20 to -70 °C under sterile conditions after opening.
Buffer
Supplied as a 0.2 μm filtered solution in Sodium Acetate, CaCl2 and NaCl.
Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain
Assay Procedure
Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 7.5 (TCNB)
Recombinant Human Aggrecan G1-IGD-G2 (rhAggrecan) Domains (Catalog # 1220-PG)
Recombinant Human ADAMTS1 (rhADAMTS1) (Catalog # 2197-AD)
SDS-PAGE with Silver Staining
Dilute rhAggrecan to 200 µg/mL in Assay Buffer.
Dilute rhADAMTS1 to 56 µg/mL in Assay Buffer.
Mix 25 µL of 200 µg/mL rhAggrecan, 10 µL of 56 µg/mL rhADAMTS1, and 15 µL of Assay Buffer.
Incubate at 37 °C for 24 hours.
Include controls containing equal volumes of 200 µg/mL rhAggrecan and Assay Buffer. Incubate one tube at 37 °C and the other at -20 °C for 24 hours.
Stop the reaction by mixing equal volumes of the incubated samples and reducing gel loading buffer.
Analyze the cleavage by SDS PAGE followed by protein silver staining [or Western blot using anti-human aggrecan antibodies (Catalog # AF1220 and MAB1220)].
Per Reaction:
rhADAMTS1: 11.2 µg/mL
rhAggrecan: 100 µg/mL
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human ADAMTS1 Protein, CF
a disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
ADAM-TS 1
ADAMTS1
ADAM-TS1
ADAMTS-1
C3-C5
METH1
METH-1
Background
ADAMTS1 (a disintegrin and metalloproteinase with thrombospondin motifs 1), also known as METH1, is the founding member of the family of secreted zinc proteases with a multi-domain structure (1-3). The protein precursors consist of signal peptide and following domains: pro, catalytic, disintegrin-like, TS type 1 motif, cysteine‑rich, spacer and a variable number of TS type 1 motifs. Based on their substrate specificity, ADAMTS1 and associated family members may be key enzymes in degradation of cartilage leading to inflammation and arthritis (4). It is an active protease cleaving alpha -2-macroglobulin (5), aggrecan (6), and versican (7). Compared to ADAMTS4 (aggrecanase 1) and ADAMTS5 (aggrecanase 2), the aggrecanase activity of ADAMTS1 is lower. However, its activity can be enhanced by the binding of cofactor such as fibulin-1 (8). The aggrecanase activity can be inhibited using 5 mM 1,10 Phenanthroline. ADAMTS1 is essential for normal growth and the structure and function of the kidneys, adrenal glands and female reproductive organs (9). It also plays an important role in atherosclerosis (10). It has been shown to inhibit endothelial cell proliferation by direct binding and sequestration of VEGF165 and to inhibit fibroblast migration at high concentrations by binding to FGF-2 (11, 12). The purified recombinant human ADAMTS1 starts at the N‑terminus of the catalytic domain and ends in the beginning of the spacer region.
Vazquez, F. et al. (1999) J. Biol. Chem. 274:23349.
Kuno, K. et al. (1997) J. Biol. Chem. 272:556.
Porter, S. et al. (2005) Biochem. J. 386:15.
Nagase, H. and M. Kashiwagi (2003) Arthritis Res. Ther. 5:94.
Kuno, K. et al. (1999) J. Biol. Chem. 274:18821.
Kuno, K. et al. (2000) FEBS Lett. 478:241.
Russel, D. L. et al. (2003) J. Biol. Chem. 278:42330.
Lee, N., et al. (2005) J. Biol. Chem. 280:34796.
Shindo, T., et al. (2000) J. Clin. Invest. 105:1345.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human ADAMTS1 Protein, CF and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.